The store will not work correctly when cookies are disabled.
(S)-5-oxopyrrolidine-2-carboxamide
ID: ALA4243050
Cas Number: 16395-57-6
PubChem CID: 444439
Product Number: O697739, Order Now?
Max Phase: Preclinical
Molecular Formula: C5H8N2O2
Molecular Weight: 128.13
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)[C@@H]1CCC(=O)N1
Standard InChI: InChI=1S/C5H8N2O2/c6-5(9)3-1-2-4(8)7-3/h3H,1-2H2,(H2,6,9)(H,7,8)/t3-/m0/s1
Standard InChI Key: WGOIHPRRFBCVBZ-VKHMYHEASA-N
Molfile:
RDKit 2D
9 9 0 0 0 0 0 0 0 0999 V2000
3.2151 -13.6116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0364 -13.6116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2908 -12.8308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6278 -12.3487 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9649 -12.8308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1835 -12.5786 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9981 -12.4147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7142 -12.8157 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9893 -11.6016 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
5 6 2 0
3 7 1 6
7 8 1 0
7 9 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 128.13 | Molecular Weight (Monoisotopic): 128.0586 | AlogP: -1.25 | #Rotatable Bonds: 1 |
Polar Surface Area: 72.19 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.33 | CX Basic pKa: ┄ | CX LogP: -1.70 | CX LogD: -1.70 |
Aromatic Rings: ┄ | Heavy Atoms: 9 | QED Weighted: 0.46 | Np Likeness Score: 0.04 |
References
1. Gang FL, Zhu F, Li XT, Wei JL, Wu WJ, Zhang JW.. (2018) Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead., 26 (16): [PMID:30119995] [10.1016/j.bmc.2018.07.041] |
2. Homerin G, Jawhara S, Dezitter X, Baudelet D, Dufrénoy P, Rigo B, Millet R, Furman C, Ragé G, Lipka E, Farce A, Renault N, Sendid B, Charlet R, Leroy J, Phanithavong M, Richeval C, Wiart JF, Allorge D, Adriouch S, Vouret-Craviari V, Ghinet A.. (2020) Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease., 63 (5): [PMID:31525963] [10.1021/acs.jmedchem.9b00584] |